Researchers create painkillers without side effects
Published: 2017-03-04 17:30:49.0 BdST Updated: 2017-03-04 17:30:49.0 BdST
Researchers have discovered a new way of developing painkillers that act only on inflamed tissues, while keeping healthy ones unaffected, suggesting that the severe side effects currently associated with these medicines might be avoided.
When used in an animal model, their prototype of a morphine-like molecule was able to produce substantial pain relief in inflamed tissues without severe side effects, according to a study published in the journal Science.
The team of researchers used computational simulation to analyse interactions at opioid receptors -- the cell's docking sites for painkillers.
"By analysing drug-opioid receptor interactions in damaged tissues, as opposed to healthy tissues, we were hoping to provide useful information for the design of new painkillers without harmful side effects," said Christoph Stein from Charite - Universitatsmedizin Berlin in Germany.
Opioids are a class of strong pain killers and are mainly used to treat pain associated with tissue damage and inflammation, such as that caused by surgery, nerve damage, arthritis or cancer.
Common side effects associated with their use include drowsiness, nausea, constipation and dependency and, in some cases, respiratory arrest.
In this study, the the researchers showed that they were able to analyse morphine-like molecules and their interactions with opioid receptors.
They were able to successfully identify a new mechanism of action, which is capable of producing pain relief only in the desired target tissues -- those affected by inflammation.
The new findings could lead to treating postoperative and chronic inflammatory pain without causing side effects.
Doing so would substantially improve patient quality of life.
Any unauthorised use or reproduction of bdnews24.com content for commercial purposes is strictly prohibited and constitutes copyright infringement liable to legal action.
- Government finding ways to cap stent prices in Bangladesh: DG health services
- Rise of superbug tuberculosis hampers global control efforts
- Trump tries to rally support for healthcare bill
- Graphic health warning on packs: Tobacco companies 'continue to flout rules' in Bangladesh
- Bangladesh vows to eradicate TB
- Republican plan to repeal Obamacare would leave millions uninsured: report
- UK’s WHO DG candidate David Nabarro seeks Bangladesh vote
- 500 kg Egyptian woman undergoes weight-loss surgery
- Shuchona Foundation signs MoU with BPATC to help bureaucrats know neurodevelopment disorders
- Bangladeshi bureaucrats to get knowledge on ‘neurodevelopment disorders’
- Former Indian army veterans all praise for Bangladesh para-commandos
- Rain sinks Sri Lanka hopes after Mendis century, Taskin hat-trick in Dambulla
- Bombs turned Atia Mahal into a death trap, says army after Operation Twilight
- Autopsy done on bodies of two militants killed in Sylhet
- Police get control of Sylhet’s 'Atia Mahal' as army ends 'Operation Twilight'
- Visitors barred at Dhaka airport terminals to beef up security ahead of IPU Assembly
- Security forces raiding two militant hideouts in Moulvibazar
- No cause for satisfaction over 'successes in a few anti-terror raids', says BNP chief Khaleda
- Bangladesh information minister backs controversial Section 57 of ICT Act
- Messi banned for four international matches